Buy Tcr2 Therapeutics Inc Stock | TCRR Stock Price & Latest News | Public.com
TCRR

Tcr2 Therapeutics Inc

$0.00 (0.00%)Today
    View Tcr2 Therapeutics Inc (TCRR) stock trends here

    About TCRR

    TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering t-cells for cancer therapy. The firm offers cancer therapy, t-cell biology, immunology and molecular biology. It also engages in the research and collaboration with acad...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.23
    -0.45
    -0.68
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.56

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,06B
    Volume48,31k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$35.86
    1 Year Low$5.84
    Open$26.52
    High$27.73
    Low$26.52

    Buy any stock with any amount of money.

    Download the App
    Download the app